Total Revenue
West Pharmaceutical Services Total Revenue increased by 5.0% to $844.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.0%, from $698.00M to $844.90M. Over 4 years (FY 2021 to FY 2025), Total Revenue shows relatively stable performance with a 2.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Detailed definition
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Peer comparison
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $723.60M | $706.50M | $730.80M | $720.00M | $771.30M | $686.90M | $708.70M | $716.60M | $753.80M | $747.40M | $732.00M | $695.40M | $702.10M | $746.90M | $748.80M | $698.00M | $766.50M | $804.60M | $805.00M | $844.90M |
| QoQ Change | — | -2.4% | +3.4% | -1.5% | +7.1% | -10.9% | +3.2% | +1.1% | +5.2% | -0.8% | -2.1% | -5.0% | +1.0% | +6.4% | +0.3% | -6.8% | +9.8% | +5.0% | +0.0% | +5.0% |
| YoY Change | — | — | — | — | +6.6% | -2.8% | -3.0% | -0.5% | -2.3% | +8.8% | +3.3% | -3.0% | -6.9% | -0.1% | +2.3% | +0.4% | +9.2% | +7.7% | +7.5% | +21.0% |
Business Segments — Proprietary Products
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Proprietary Products | $559.70M | $601.40M | $613.90M | $563.00M | $619.80M | $647.50M | $661.80M | $694.30M |
| West Vantage | — | — | — | — | — | — | — | $150.60M |
| Contract-Manufactured Products | $142.40M | $145.50M | $134.90M | $135.00M | $146.70M | $157.10M | $143.20M | — |
| Total | $702.10M | $746.90M | $748.80M | $698.00M | $766.50M | $804.60M | $805.00M | $844.90M |
Contract-Manufactured Products was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Business Segments — Packaging Systems
| Segment | Q2 '21 | Q3 '21 | Q2 '22 | Q3 '22 |
|---|---|---|---|---|
| Packaging Systems | $587.30M | $577.00M | $653.70M | $567.00M |
| Delivery Systems | $136.40M | $129.70M | $117.80M | $120.00M |
| Total | $723.60M | $706.50M | $771.30M | $686.90M |
Delivery Systems, Packaging Systems were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Geographic Breakdown
| Segment | FY'23 | FY'24 |
|---|---|---|
| Other European countries | $388.10M | $385.50M |
| Other | $348.50M | $339.00M |
| Total | $2.95B | $2.89B |
All segment values are derived from annual filings.
Total Revenue at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's total revenue?
- West Pharmaceutical Services (WST) reported total revenue of $844.90M in Q1 2026.
- How has West Pharmaceutical Services's total revenue changed year-over-year?
- West Pharmaceutical Services's total revenue increased by 21.0% year-over-year, from $698.00M to $844.90M.
- What is the long-term trend for West Pharmaceutical Services's total revenue?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's total revenue has grown at a 2.1% compound annual growth rate (CAGR), from $2.83B to $3.07B.
- What does total revenue mean?
- The total amount of money a company brings in from its primary business activities before any expenses.